Fear of the working dead?
All signs point to becoming a lab zombie?
Already turned into a work zombie?
No worries, there’s hope and a cure!
We are happy to announce this year's
MDC/FMP PhD Retreat
26th - 28th August 2019
We provide you with
Many talks and posters by you
Games and team building events
100 PhD students
Inspiring people around
Opportunities to network and collaborate
... and cash prizes for the best posters and talks!
Karen Sarkisyan completed his PhD on fluorescent protein development with Konstantin Lukyanov and Alexander Mishin at the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry in Moscow and then worked on protein evolution with Fyodor Kondrashov at the Barcelona Institute of Science and Technology and in Vienna. Later, Karen moved to the MRC London Institute of Medical Science (LMS) in September 2018 to start his new lab.
Karen´s lab work focuses in several research directions, both basic and applied, from studying the structure-function relationship in proteins to engineering bacterial strains that can perform directed evolution without human involvement. They approach these and other problems from the perspective of synthetic biology, investing time into automation of molecular biology routines and creating new molecular technologies for light-based computation and cell communication. Additionally, they will work on studying structure-function relationship in proteins with the aim to compare properties of various regions of the protein sequence space in a systematic manner.
Karen Sarkisyan on
Jan Philipp Junker
Jan Philipp Junker studied Physics at the Technical University of Munich, Germany, where he also obtained his PhD in Biophysics in 2009. He worked as a postdoctoral associate at MIT in Cambridge, USA, and senior postdoc at Hubrecht Institute in Utrecht, Netherlands, under the supervision of Alexander van Oudenaarden. Since 2016 Jan Philipp Junker is a group leader at BIMSB, MDC in Berlin.
His lab studies embryonic development combined with methods from biophysics and systems biology to understand mechanisms that underly phenotypic diversity in isogenic populations and ensure robust patterning in the presence of perturbations. He received several awards and fellowships and an ERC starting grant for the quantitative analysis of variability and robustness in spatial pattern formation. Just last year his work on massively parallel lineage tracing during zebrafish development was selected as Science’s Breakthrough of the Year 2018.
Claudia Noack studied Biotechnology at the Beuth University of Applied Sciences followed by Molecular Medicine at Charité Medical University in Berlin. She worked at the MDC and FMP focusing on signaling pathways in murine hearts and cardiac progenitor cells in the field of endogenous cardiac regeneration. Before receiving her PhD in Biochemistry from FU Berlin in 2013, she moved to the Institute of Pharmacology & Toxicology at University Medical Center Göttingen, Germany, in 2012 as a postdoctoral researcher studying Wnt signaling in healthy and failing hearts as well as in human embryonic stem cell (hESC)-derived heart muscle models to identify new targets for pharmaco-regeneration.
Claudia Noack specialized in genome editing techniques and in the cardiovascular field with the aim to understand cardiac remodeling processes and to identify potential new pharmacological targets for heart failure treatment. Since 2017 Dr. Claudia Noack works as Head of Laboratory in the R&D Department of Target Discovery Technologies at Bayer AG in Berlin, Germany.
Claudia Noack on
Registration for the PhD Retreat 2019 is closed.
Clara Vazquez Garcia